추가 설명:
Lyophilization Technology, Inc. manufactures clinical supplies spanning sterile pre-clinical through Phase II materials, in both lyophilized and liquid form, packaged in vials, cartridges, bulk, or specialized delivery systems, with containment suited to biologics, cytotoxic agents, and highly potent APIs. Separate controlled areas handle warehousing, material prep, compounding, filling, inspection, and packaging, while the aseptic suite uses HEPA-filtered unidirectional airflow, containment, and isolation technology; the facility is inspected and approved for BSL-2 materials and qualified for containment and aseptic processing, with strict environmental controls supporting high finished-product purity across aseptic processing, isolation/containment, and dedicated/disposable, qualified and validated equipment.
평가 & 댓글 남기기